Clinical Trials Sponsored by Norwegian Underwater Intervention (NUI)
Total 1 results
-
Norwegian Underwater Intervention (NUI)Western Norway University of Applied Sciences; Helse-Bergen HFWithdrawn
Sponsors and Collaborators
- Elim Pediatric Pharmaceuticals Inc.
- AMTC & Associates
- Victor Montori
- Fondren Orthopedic Group L.L.P.
- The Fifth Affiliated Hospital of Zunyi Medical College
- Diego Hernan Giunta, MD
- Ilustre Colegio Profesional de Fisioterapeutas de la Comunidad de Madrid
- San MediTech(Huzhou)Co.,Ltd.
- Cardresearch
- Alberta Children's Hospital, Calgary, Canada
- Norsk Proteinintolerance, Norway
- University Centre for Chronic Diseases Dekkerswald, Groesbeek, NL
- University Medical Center Goettingen
- Caritas Freetown
- Rui-hua Xu, MD, PhD
- CRMBM-CEMEREM
- Celtaxsys Aus Pty Limited
- Societa Italiana di Endoscopia Digestiva
- Donders Institute for Brain, Cognition and Behavior
- ProteoSys AG
- View Full List
Medical Conditions
- Postcomatose Unawareness State
- Tube Disorders Eustachian
- Fever, Sweats, and Hot Flashes
- Fibromyalgia Syndrome, Primary
- Gynecologic Cancer
- Atrial Fibrillation, Postoperative
- Plasmodium Falciparum Malaria (Drug Resistant)
- Malignant Ascites Due to Epithelial Carcinoma
- Non-compressible Torso Hemorrhage
- Spermatogenesis Arrest
- Stereotactic Radioablation for Ventricular Tachycardia
- Tularaemia
- Analgesics, Antipyretics, and Antirheumatics Causing Adverse Effects in Therapeutic Use
- Normal Diameter of Optic Nerve
- Prostate Cancer Recurrent
- Lymphedema of Arm
- Auditory Hallucination, Verbal
- Disturbance of Activity and Attention
- Orbital Tumor
- Non-dystrophic Myotonias
- View Full List
Drug Interventions
- Oxycodone, fentanyl
- Indoximod
- Lamivudine
- Cetrorelix 78 mg + 78 mg
- Mupirocin Calcium
- PF-00868554
- Insulin
- Bortezomib/dexamethasone
- Methotrexate
- SERETIDE Diskus
- Epimedium Prenylflavonoids Extract
- Ruxolitinib
- Enzalutamide, Abiraterone
- CTx-1301-Dexmethylphenidate 18.75mg (randomized fixed dose)
- HB-202 / HB-201 alternating intravenous administration + standard of care regimen including pembrolizumab.
- Cytarabine ARA-C
- Polyethylene glycol 3350
- Atezolizumab
- Flibanserin 100 mg dose every evening
- Topotecan
- View Full List
CROs by country
- Contract Research Organizations in Bahrain
- Contract Research Organizations in Belgium
- Contract Research Organizations in Bosnia & Herzegovina
- Contract Research Organizations in Bulgaria
- Contract Research Organizations in Costa Rica
- Contract Research Organizations in Denmark
- Contract Research Organizations in Hungary
- Contract Research Organizations in Lebanon
- Contract Research Organizations in Paraguay
- Contract Research Organizations in Senegal
- Contract Research Organizations in South Africa
- Contract Research Organizations in Sweden
- Contract Research Organizations in Uruguay
- CRO list by country